Balloon-Assisted Enteroscopic Treatment for Phytobezoar
Launched by SHANDONG UNIVERSITY · Mar 10, 2025
Trial Information
Current as of April 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Retrospectively collect data from patients who underwent balloon-assisted enteroscopic treatment for phytobezoar at our hospital.
- Exclusion Criteria:
- • Patients with incomplete clinical data.
Trial Officials
Xiuli Zuo
Study Director
Qilu Hospital of Shandong University
About Shandong University
Shandong University is a prestigious research institution located in Jinan, China, renowned for its commitment to advancing medical and scientific knowledge through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment conducive to groundbreaking studies that address critical healthcare challenges. Shandong University actively engages in clinical research to evaluate new therapies and interventions, contributing to the global body of medical literature and enhancing patient care. Its dedicated team of researchers and clinicians ensures adherence to the highest ethical standards and regulatory compliance, positioning the university as a key player in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Shandong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported